AGIL f(x)

AGIL f(x) specializes in building custom agentic AI systems designed specifically for the life sciences sector. Operating from Philadelphia with a team of 10 to 15 employees, the company focuses on creating intelligent, adaptive agents that handle complex operational workflows in biotech, pharmaceutical, and medical technology organizations. Their AI architects and engineers combine technical expertise with deep understanding of regulatory requirements that govern the life sciences industry. The company's core service offering centers on AI development, which represents 70% of their work, complemented by low-code and no-code development solutions. AGIL f(x) serves primarily midmarket companies with revenues between $10 million and $1 billion, as well as smaller businesses seeking to automate processes while maintaining compliance standards. Their approach transforms manual, complex operational challenges into autonomous systems that perform tasks without sacrificing the regulatory integrity essential in heavily regulated sectors. While life sciences remains their primary focus, AGIL f(x) has expanded their client base across multiple industries including consumer products, advertising and marketing, business services, education, financial services, medical, real estate, retail, and eCommerce. The company maintains a 4.7 out of 5.0 rating on Clutch based on 10 client reviews. Their expertise in building agentic systems—AI that can perceive environments, make decisions, and take actions autonomously—positions them at the intersection of artificial intelligence advancement and practical business application.